Skip to content

US · SCNX · MEDICAL - HEALTHCARE INFORMATION SERVICES

Scienture Holdings, Inc. (SCNX) intrinsic value and stock valuation

$2.28as of 2026-11-21 · Mkt cap 6M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Scienture Holdings, Inc. DCF and intrinsic value

InvestorsCraft values SCNX with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SCNX’s statements →

Scienture Holdings, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Commack, NY 11725 scienture.com

How the business is doing

Fiscal 2007–2025, USD

Revenue
$430K-52.1% 5y CAGRd
20072025
Net income
-$-41.51M
20072025
Free cash flow
-$-13.38B
20072025
Total equity
$70.1M+51.9% 5y CAGRd
20072025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2007–2025, USD
20252024202320222021
Revenue$430K$140K$1.36M$10.3M$9.89M
Operating income-$-16.24M-$-14.7M-$-4.4M-$-2.92M-$-5.29M
Net income-$-41.51M$9.07M-$-17.84M-$-3.47M-$-5.32M
EPSd-$-270.48K$2.48M-$-7.5M-$-6.2M-$-9.85M
Operating cash flow-$-13.38B-$-14.27M-$-2.23M-$-1.56M-$-2.57M
Capital expenditure$0.00-$-10K$0.00-$-450K-$-20K
Free cash flow-$-13.38B-$-14.28M-$-2.23M-$-1.56M-$-2.59M
Total assets$84.2M$104.9M$12.5M$3.71M$5.77M
Total debt$20K$3.53M$6.76M$1.58M$1.25M
Net debt-$-6.64M$3.22M$6.76M$490K-$-1.87M
Total equity$70.1M$79.1M$540K$340K$3.77M
Cash and short-term investments$6.66M$310K$0.00$1.09M$3.12M
Income statement
20252024202320222021
Revenue$430K$140K$1.36M$10.3M$9.89M
Cost of revenue$100K$130K$1.31M$4.73M$5.14M
Gross profit$330K$10K$50K$5.52M$4.75M
Research and development expenses$1.96M$2.24M$100K$990K$900K
Selling, general and administrative expenses$14.5M$12.1M$4.35M$6.57M$7.54M
Other expenses$100K$420K$100K$880K$1.6M
Operating expenses$16.6M$14.7M$4.45M$8.44M$10M
Cost and expenses$16.7M$14.8M$5.76M$13.2M$15.2M
Interest income$300K$140K$0.00$20K$0.00
Interest expense$4.08M$1.34M$1.14M$340K$20K
Depreciation and amortization$490K$50K$1.05M$190K$140K
Ebitda-$-38.93M-$-17.39M-$-6.29M-$-1.87M-$-5.15M
Operating income-$-16.24M-$-14.7M-$-4.4M-$-2.92M-$-5.29M
Total other income/expenses, net-$-27.26M-$-4.08M-$-4.09M$510K-$-20K
Income before tax-$-43.51M-$-18.78M-$-8.48M-$-2.4M-$-5.32M
Income tax expense-$-1.99M-$-530K$0.00$0.00$0.00
Net income-$-41.51M$9.07M-$-17.84M-$-3.47M-$-5.32M
Weighted average shares outstanding$153.5M$3.38M$760K$560K$540K
Weighted average diluted shares outstanding$153.5M$3.65M$2.38M$560K$540K
Balance sheet
20252024202320222021
Cash and short-term investments$6.66M$310K$0.00$1.09M$3.12M
Net receivables$730K$5.45M$2.52M$630K$980K
Inventory$210K$0.00$0.00$70K$60K
Total current assets$7.92M$6.31M$2.75M$2.09M$4.37M
Property, plant and equipment, net$40K$220K$200K$1.12M$1.33M
Goodwill and intangible assets$71M$97.8M$8.96M$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$76.3M$98.6M$9.78M$1.62M$1.39M
Total assets$84.2M$104.9M$12.5M$3.71M$5.77M
Accounts payable$1.44M$2.9M$1.46M$530K$480K
Short-term debt$20K$2.76M$6.56M$360K$360K
Deferred revenue$0.00$0.00$0.00$10K$0.00
Total current liabilities$2.74M$7.91M$11.6M$2.15M$930K
Long-term debt$0.00$770K$200K$1.22M$1.07M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$11.3M$17.9M$430K$1.22M$1.07M
Capital lease obligations$20K$220K$210K$1.08M$1.25M
Total liabilities$14.1M$25.8M$12M$3.37M$2M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-80.55M-$-39.04M-$-33.25M-$-19.72M-$-16.25M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$70.1M$79.1M$540K$340K$3.77M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$20K$3.53M$6.76M$1.58M$1.25M
Net debt-$-6.64M$3.22M$6.76M$490K-$-1.87M
Cash flow statement
20252024202320222021
Net income-$-41.51B-$-18.24M-$-8.48M-$-2.4M-$-5.32M
Depreciation and amortization$455.9M$50K$1.05M$190K$140K
Stock-based compensation$2.07B$0.00$260K$250K$180K
Change in working capital-$-3.07M-$-2.6M$5.51M$260K$1.08M
Accounts receivable-$-800K-$-2.93M-$-550K-$-510K$300K
Inventory-$-210K$0.00$4.23M-$-50K$830K
Accounts payable-$-1.57M$450K$1.61M$200K$220K
Net cash provided by operating activities-$-13.38B-$-14.27M-$-2.23M-$-1.56M-$-2.57M
Investments in property, plant and equipment$0.00-$-10K$0.00-$-450K-$-20K
Acquisitions, net$0.00$130K-$-340K$0.00$0.00
Net cash used for investing activities$0.00$27.6M-$-280K-$-430K-$-20K
Common stock issued$26.3M$30K$520K$130K$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00-$-14.86M$0.00$0.00$0.00
Net cash used for financing activities$19.7B-$-12.98M$1.41M-$-40K-$-210K
Net change in cash$6.35B$310K-$-1.09M-$-2.03M-$-2.8M
Cash at end of period$6.66B$310K$0.00$1.09M$3.12M
Operating cash flow-$-13.38B-$-14.27M-$-2.23M-$-1.56M-$-2.57M
Capital expenditure$0.00-$-10K$0.00-$-450K-$-20K
Free cash flow-$-13.38B-$-14.28M-$-2.23M-$-1.56M-$-2.59M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Scienture Holdings, Inc.

        As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.

        CEO
        Shankar Hariharan
        Employees
        9
        Beta
        3.96

        Explore

        Frequently asked questions

        What is the intrinsic value of Scienture Holdings, Inc. (SCNX)?

        InvestorsCraft does not currently publish an intrinsic value for SCNX. How the IC value is calculated.

        Is SCNX undervalued?

        InvestorsCraft does not publish an undervaluation signal for SCNX at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.